WP3 Peptides and More – Research Peptides Index

🧬 GLP3 Peptides • Research-Only Knowledge Base

GLP3 Peptides, Retatrutide & Advanced Research Compounds

This hub organizes GLP3-associated peptides, GLP-1/GLP-2/GLP-3 analogues, growth factors, mitochondria-active fragments, and metabolic research tools into a single, structured reference.

Every compound links to a dedicated documentation page covering identity, lab-only applications, storage & stability, chain-of-custody checklists, and citations to peer-reviewed literature where appropriate. No dosing, no medical claims, no consumer promotion.

Research Only — Not for human or veterinary use
QC, COA & documentation focus
GLP-1 / GLP-2 / GLP-3 axis
Mitochondrial & regenerative peptides
Metabolic & neuropeptide library
Core Tissue Repair & Regeneration Peptides
Tendon / GI / Microvasculature Models

BPC-157 10mg

Gastric pentadecapeptide fragment explored in preclinical settings for angiogenesis, tendon and ligament repair, and GI integrity.

Covers: stability, light protection, aliquot mapping, COA verification.
Cytoskeletal / Angiogenic Fragment

TB-500 10mg

Thymosin beta-4 fragment studied for actin modulation, tissue repair, and neovascularization in controlled bench and animal models.

Emphasis: cold-chain integrity, multi-site aliquoting, documentation SOPs.
Dermal / ECM / Copper Peptide

GHK-Cu 100mg

Tripeptide–copper complex evaluated for collagen support, wound models, and cosmetic research formulations under controlled lab conditions.

Includes: metal-binding considerations & oxidative stability notes.
Metabolic Axis • GLP-1 / GLP-2 / GLP-3 & Related
Receptor-Targeted Peptide

GLP-3R 10mg / 30mg

Research peptide positioned within the incretin family for in vitro receptor studies and comparative signaling assays.

Focus: receptor selectivity, batch traceability, inert excipients.
Intestinal Integrity / GLP-2 Analogue

GLP-2T 10mg / 20mg

GLP-2 analogue referenced in models of mucosal integrity and nutrient absorption; handled under strict cold-chain conditions.

GLP-1 / GIP / Glucagon Triple Agonist*

GLP3 Retatrutide Knowledge Hub

Central index tracking publicly available data on retatrutide as an investigational triple agonist (GLP-1, GIP, glucagon) in obesity and cardiometabolic trials.

*Experimental; not approved. Summaries reference sponsor trial data & peer-reviewed publications only.
Mitochondrial, Cognitive & Performance Peptides
Mitochondrial-Derived Peptide

MOTS-c 40mg

Short peptide encoded by mitochondrial DNA; investigated for metabolic flexibility and exercise-related models.

Neuropeptide Fragment

Semax 10mg

ACTH(4–10) analogue evaluated in models of neuroprotection, cognition, and stress response; storage stability and light protection are critical.

Anxiolytic-Analog Peptide

Selank 5mg

Heptapeptide studied in models of anxiety and immune modulation with emphasis on sterility and batch identity.

Endocrine, Sexual Function & Supportive Agents
GHRH + GHRP Combo

CJC-1295 + Ipamorelin 10mg

Dual-agonist combination referenced for pulsatile GH research models. Documentation centers on combo ratios & stability.

Growth Factor Analogue

IGF-1 LR3 1mg

Long-acting IGF-1 analogue utilized in receptor-binding and cell-culture research; requires precise concentration mapping.

MC4R-Targeted Peptide

PT-141 10mg

Melanocortin receptor agonist investigated in sexual function models. Coverage: photostability, solvent selection, documentation.

Systemic Support & Redox
Redox Cofactor

NAD+ 1000mg

Oxidoreductase cofactor used in cell and mitochondrial assays. Documentation emphasizes pH, light protection, and degradation pathways.

Tripeptide Antioxidant

Glutathione 1500mg

Endogenous antioxidant tripeptide applied in oxidative stress and detox models; sensitive to pH, oxygen, and metal contaminants.

Tetrapeptide Longevity Models

Epitalon 50mg

Tetrapeptide explored in circadian and telomere research; requires meticulous long-term stability tracking and provenance records.

How to Use This Index (For Labs & Manufacturers)

1. Documentation first.

Each peptide page is built to support audit-ready documentation: identity methods, purity thresholds, storage logs, aliquot maps, and lot-level traceability. Vendors reviewing this library should be able to align their COAs and SOPs directly against these structures.

2. Evidence without hype.

Where data exists, summaries emphasize study design, model type (in vitro / in vivo / clinical), magnitude of effect, and limitations— not social media anecdotes. Experimental agents (including retatrutide) are clearly labeled as investigational.

3. Strict non-clinical stance.

  • No dosing instructions or treatment protocols.
  • No claims of curing, treating, or preventing disease.
  • No encouragement of unsupervised or grey-market use.

4. Fit for acquisition & partnership.

This structure is intentionally “manufacturer-grade”: a future acquirer can plug their validated specs, certificates, and pharmacovigilance data into an already coherent information architecture.

For Research Use Only. Not for human or veterinary consumption, diagnosis, treatment, or therapeutic use. Content is educational, neutral, and non-promotional.